Casey L. Bales

A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes

Guanglong Jiang, B. Schneider, Xi Wu, 2022, Nature Communications.

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.

J. Gregg, C. Savran, C. Isaacs, 2020, JAMA oncology.

TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis

S. Badve, H. Nakshatri, S. Perkins, 2015, Breast Cancer Research and Treatment.

The impact of SBF2 on taxane-induced peripheral neuropathy

Guanglong Jiang, B. Schneider, J. Wan, 2022, PLoS genetics.

BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer

J. Gregg, C. Isaacs, S. Badve, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract GS5-02: Detection of circulating tumor DNA (ctDNA) after neoadjuvant chemotherapy is significantly associated with disease recurrence in early-stage triple-negative breast cancer (TNBC): Preplanned correlative results from clinical trial BRE12-158

J. Gregg, C. Isaacs, S. Badve, 2020 .

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

B. Schneider, Katharine J. Head, Casey L. Bales, 2022, PEC innovation.